S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCTION AND NILOTINIB OR PEG-INTERFERON ΑLPHA MAINTENANCE THERAPY FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS. THE TIGER TRIAL.

Detalles Bibliográficos
Autores principales: Hochhaus, Andreas, Burchert, Andreas, Saußele, Susanne, Baerlocher, Gabriela M, Mayer, Jiri, Brümmendorf, Tim H, La Rosee, Paul, Heim, Dominik, Krause, Stefan W, Le Coutre, Philipp, Fabisch, Christian, Rinke, Jenny, Lange, Thoralf, Fabarius, Alice, Lorch, Marcel, Hänel, Mathias, Stegelmann, Frank, Franke, Georg-Nikolaus, Radsak, Markus, Kunzmann, Volker, Himsel, Danny, Kohn, Denise, Lang, Thomas, Hehlmann, Rüdiger, Ernst, Thomas, Pfirrmann, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Oral Sessions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428351/
http://dx.doi.org/10.1097/01.HS9.0000967540.46956.59

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428351/
http://dx.doi.org/10.1097/01.HS9.0000967540.46956.59

Ejemplares similares